多变量预测模型开发与验证:五项随机试验队列中中心静脉导管尖端定植的预测
本研究基于五项多中心随机对照试验的回顾性队列,开发并验证了预测中心静脉导管尖端定植的CVC-OUT评分。训练队列纳入3899根导管(15%定植),识别出肥胖、糖尿病、导管类型、置入部位、置管序次和置管时长等独立危险因素;评分在训练队列AUC为0.69(95%CI 0.67-0.72),外部验证队列(6848根导管,9%定植)AUC为0.60(95%CI 0.58-0.62)。在因疑似导管相关感染拔除的1469根导管中,82%未定植;评分<6分的阴性预测值为94%(95%CI 93%-95%)。作者认为该评分区分能力中等,但高阴性预测值可能有助于减少不必要的拔管,锁骨下部位是唯一可改变的危险因素。
要点
- CVC-OUT评分<6分对导管尖端定植的阴性预测值为94%(95%CI 93%-95%),在因疑似导管相关感染拔除的1469根导管中82%未定植。
- 评分在训练队列的AUC为0.69(95%CI 0.67-0.72),在外部验证队列的AUC为0.60(95%CI 0.58-0.62),区分能力中等。
- 评分项目及分值:肥胖1分、糖尿病1分、透析导管1分、颈静脉置入4分、股静脉置入5分、第二根或后续导管1分、置管时长≥5天2分。
- 锁骨下置入是唯一可改变且最强的降低导管尖端定植可能性的因素。
适用人群与场景
- ICU中连续置入的中心静脉导管,来自五项多中心随机对照试验(CATHEDIA、3SITES、CLEAN、DRESSING2、ELVIS)的回顾性队列。
- 因疑似导管相关感染而拔除的导管共1469根。
诊断标准与关键阈值
- 导管尖端定植定义为每毫升生长≥10³个菌落形成单位。
- CVC-OUT评分阈值:<6分用于预测低定植风险。
研究设计与关键结果
- 研究类型:基于五项多中心随机对照试验的回顾性队列研究,对连续中心静脉导管进行系统导管尖端培养。
- 训练队列(CATHEDIA和3SITES试验):3899根导管,575根(15%)定植;经多变量分析识别定植危险因素,并在500个自助样本中内部验证后构建CVC-OUT评分。
- 训练队列中与定植显著独立相关的因素及分值:肥胖1分、糖尿病1分、导管类型为透析导管1分、置入部位为颈静脉4分、股静脉5分、导管序次为第二根或后续1分、置管时长≥5天2分。
- 训练队列CVC-OUT评分AUC为0.69(95%CI 0.67-0.72)。
- 外部验证队列(CLEAN、DRESSING2和ELVIS试验):6848根导管,588根(9%)定植;CVC-OUT评分AUC为0.60(95%CI 0.58-0.62)。
- 总体人群中因疑似导管相关感染拔除的1469根导管中,1200根(82%)未定植。
- CVC-OUT评分<6分的阴性预测值为94%(95%CI 93%-95%)。
证据类型、等级与局限
- 证据类型:基于五项多中心随机对照试验的回顾性队列研究,包含内部验证(500个自助样本)和外部验证。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为CVC-OUT评分区分导管尖端定植的能力中等,但高阴性预测值可能有助于减少不必要的中心静脉导管拔除。
- 作者认为优先选择锁骨下置入部位是唯一可改变且最强的降低导管尖端定植可能性、进而降低导管相关感染风险的因素。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The majority of central venous catheters (CVC) removed in the ICU are not colonized, including when a catheter-related infection (CRI) is suspected. We developed and validated a predictive score to reduce unnecessary CVC removal.
METHODS: We conducted a retrospective cohort study from five multicenter randomized controlled trials with systematic catheter-tip culture of consecutive CVCs. Colonization was defined as growth of ≥103 colony-forming units per mL. Risk factors for colonization were identified in the training cohort (CATHEDIA and 3SITES trials; 3899 CVCs of which 575 (15%) were colonized) through multivariable analyses. After internal validation in 500 bootstrapped samples, the CVC-OUT score was computed by attaching points to the robust (> 50% of the bootstraps) risk factors. External validation was performed in the testing cohort (CLEAN, DRESSING2 and ELVIS trials; 6848 CVCs, of which 588 (9%) were colonized).
RESULTS: In the training cohort, obesity (1 point), diabetes (1 point), type of CVC (dialysis catheter, 1 point), anatomical insertion site (jugular, 4 points; femoral 5 points), rank of the catheter (second or subsequent, 1 point) and catheterization duration (≥ 5 days, 2 points) were significantly and independently associated with colonization . Area under the ROC curve (AUC) for the CVC-OUT score was 0.69, 95% confidence interval (CI) [0.67-0.72]. In the testing cohort, AUC for the CVC-OUT score was 0.60, 95% CI [0.58-0.62]. Among 1,469 CVCs removed for suspected CRI in the overall population, 1200 (82%) were not colonized. The negative predictive value (NPV) of a CVC-OUT score < 6 points was 94%, 95% CI [93%-95%].
CONCLUSION: The CVC-OUT score had a moderate ability to discriminate catheter-tip colonization, but the high NPV may contribute to reduce unnecessary CVCs removal. Preference of the subclavian site is the strongest and only modifiable risk factor that reduces the likelihood of catheter-tip colonization and consequently the risk of CRI.
CLINICAL TRIALS REGISTRATION: NCT00277888, NCT01479153, NCT01629550, NCT01189682, NCT00875069.
参考来源
- Iachkine J, Buetti N, de Grooth HJ, et al. Development and validation of a multivariable prediction model of central venous catheter-tip colonization in a cohort of five randomized trials. Crit Care. 2022. PMID: 35799302. doi:10.1186/s13054-022-04078-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。